Next Article in Journal
Regeneration during Obesity: An Impaired Homeostasis
Next Article in Special Issue
Proteomic Analysis of Tear Film Obtained from Diabetic Dogs
Previous Article in Journal
Autochthonous Yeast from Pork and Game Meat Fermented Sausages for Application in Meat Protection and Aroma Developing
Previous Article in Special Issue
Concentrations of Circulating Irisin and Myostatin in Race and Endurace Purebred Arabian Horses—Preliminary Study
 
 
Review

Selected Biological Medicinal Products and Their Veterinary Use

1
Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-718 Olsztyn, Poland
2
Sub-Department of Pharmacology, Toxicology and Environmental Protection, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 12 Akademicka St., 20-950 Lublin, Poland
*
Author to whom correspondence should be addressed.
Animals 2020, 10(12), 2343; https://doi.org/10.3390/ani10122343
Received: 26 November 2020 / Revised: 3 December 2020 / Accepted: 7 December 2020 / Published: 9 December 2020
(This article belongs to the Collection Gut and Bone in Health and Disease)
Biological drugs are a generation of drugs that have developed thanks to advances in genetic engineering and molecular biology. Biological drugs are proteins derived from living cells or obtained through the use of genetic engineering methods with a selective and specific mechanism of action. Currently, these drugs are widely used in the treatment of many human diseases, but an increasing number of drugs from this group are also being used in the treatment of animals, mainly in dermatology, rheumatology and oncology.
Definitions of biological medicinal products (BMPs) vary depending on the source. BMPs are manufactured using complex biological/biotechnological processes involving living cell lines, tissues and organisms such as microorganisms, plants, humans and even animals. Advances in modern biotechnological methods and genetic engineering have made it possible to search for new drugs with a targeted effect and simultaneous reduction of adverse effects, which has resulted in BMPs dynamically increasing their share in the pharmaceutical market. Currently, these drugs are widely used in the treatment of many human diseases, but an increasing number of drugs of this group are also being used in the treatment of animals, mainly in dermatology, rheumatology and oncology. This article presents the current state of knowledge in the field of biological medicinal products used in animal therapy. View Full-Text
Keywords: biological medicinal products; bio-similar drugs; monoclonal antibodies; fusion proteins; active substance biological medicinal products; bio-similar drugs; monoclonal antibodies; fusion proteins; active substance
MDPI and ACS Style

Zygmuntowicz, A.; Burmańczuk, A.; Markiewicz, W. Selected Biological Medicinal Products and Their Veterinary Use. Animals 2020, 10, 2343. https://doi.org/10.3390/ani10122343

AMA Style

Zygmuntowicz A, Burmańczuk A, Markiewicz W. Selected Biological Medicinal Products and Their Veterinary Use. Animals. 2020; 10(12):2343. https://doi.org/10.3390/ani10122343

Chicago/Turabian Style

Zygmuntowicz, Aleksandra, Artur Burmańczuk, and Włodzimierz Markiewicz. 2020. "Selected Biological Medicinal Products and Their Veterinary Use" Animals 10, no. 12: 2343. https://doi.org/10.3390/ani10122343

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop